Georgia B. McGaughey

Author

Also Known As

G. B. MCGAUGHEY, G. B. McGaughey, G. McGaughey, G.B. McGaughey, Georgia B McGaughey, Georgia B. McGaughey, Georgia McGaughey, Georgia B. McGaughey, McGaughey, G.B., McGaughey, Georgia

100

Publications

4.6K

Citations

H-Index

110

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Vertex Pharmaceuticals (United States)CNS Research (United States)

About

Georgia B. McGaughey is an author at United States Military Academy specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	47	2.9K
2	Natural Sciences	20	25	1.4K
3	Engineering	3	3	473
4	Social Sciences	3	3	66
5	Health Sciences	1	1	23

Georgia B. McGaughey

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
π-Stacking Interactions Georgia B. McGaughey, Marc Gagné, Anthony K. Rappé Journal of Biological Chemistry	1998	1.1K
Comparison of Topological, Shape, and Docking Methods in Virtual Screening Georgia B. McGaughey, Robert P. Sheridan, Christopher I. Bayly, Journal of Chemical Information and Modeling Drug TargetHit IdentificationVirtual Screening MethodsComputer-aided DesignChemical Biology	2007	415
Discovery of the Dual Orexin Receptor Antagonist [(7<i>R</i>)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia Christopher D. Cox, Michael J. Breslin, David B. Whitman, Journal of Medicinal Chemistry Psychotropic MedicationPharmacotherapyPrimary InsomniaMolecular PharmacologyMedicinal Chemistry	2010	367
Molecular Shape and Medicinal Chemistry: A Perspective Anthony Nicholls, Georgia B. McGaughey, Robert P. Sheridan, Journal of Medicinal Chemistry EngineeringMolecular ShapeBiomedical EngineeringPharmaceutical ChemistryMolecular Design	2010	309
D3R grand challenge 4: blind prediction of protein–ligand poses, affinity rankings, and relative binding free energies conor parks, Zied Gaieb, Michael Chiu, Journal of Computer-Aided Molecular Design Blind PredictionEngineeringProtein–ligand PosesProtein FoldingAffinity Rankings	2020	138
Discovery of 3-{5-[(6-Amino-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): A Potent, Orally Bioavailable HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor with Improved Potency against Key Mutant Viruses Thomas J. Tucker, John T. Sisko, Robert M. Tynebor, Journal of Medicinal Chemistry Molecular BiologyKey Mutant VirusesPharmacotherapyAntiviral DrugPhysical Properties	2008	132
Discovery of [(2<i>R</i>,5<i>R</i>)‐5‐{[(5‐Fluoropyridin‐2‐yl)oxy]methyl}‐2‐methylpiperidin‐1‐yl][5‐methyl‐2‐(pyrimidin‐2‐yl)phenyl]methanone (MK‐6096): A Dual Orexin Receptor Antagonist with Potent Sleep‐Promoting Properties Paul J. Coleman, John D. Schreier, Christopher D. Cox, ChemMedChem Sleep DisordersNeurotransmitterPeptide SciencePharmacotherapyExperimental Pharmacology	2012	121
First Demonstration of Cerebrospinal Fluid and Plasma Aβ Lowering with Oral Administration of a β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman Primates Sethu Sankaranarayanan, Marie A. Holahan, Dennis Colussi, Journal of Pharmacology and Experimental Therapeutics	2008	105
HIV-1 Vaccine Development: Constrained Peptide Immunogens Show Improved Binding to the Anti-HIV-1 gp41 MAb Georgia B. McGaughey, Michael Citron, Renee Danzeisen, Biochemistry ImmunologyAnti-hiv-1 Gp41 MabMolecular BiologyHiv-1 VaccineAntigen Processing	2003	101
Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs) Zhijian Zhao, S. E. Wolkenberg, Meiqing Lu, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNovel Indole-3-sulfonamidesDrug DiscoveryMedicineNatural Sciences	2007	87

Page 1